40.47
Schlusskurs vom Vortag:
$40.45
Offen:
$39.94
24-Stunden-Volumen:
7.75M
Relative Volume:
0.58
Marktkapitalisierung:
$7.46B
Einnahmen:
$640.44M
Nettoeinkommen (Verlust:
$-743.28M
KGV:
-3.5849
EPS:
-11.2888
Netto-Cashflow:
$-206.93M
1W Leistung:
-6.68%
1M Leistung:
-21.62%
6M Leistung:
-17.32%
1J Leistung:
+0.00%
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Vergleichen Sie TEM mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TEM
Tempus Ai Inc
|
40.34 | 7.46B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
VEEV
Veeva Systems Inc
|
208.85 | 36.39B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
51.26 | 9.87B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
HQY
Healthequity Inc
|
80.15 | 7.21B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
34.98 | 6.30B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
2025-02-05 | Fortgesetzt | TD Cowen | Buy |
2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
2024-12-09 | Eingeleitet | Guggenheim | Buy |
2024-11-11 | Herabstufung | Stifel | Buy → Hold |
2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
2024-07-09 | Eingeleitet | BofA Securities | Buy |
2024-07-09 | Eingeleitet | JP Morgan | Overweight |
2024-07-09 | Eingeleitet | Longbow | Buy |
2024-07-09 | Eingeleitet | Loop Capital | Buy |
2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
2024-07-09 | Eingeleitet | Needham | Buy |
2024-07-09 | Eingeleitet | Stifel | Buy |
2024-07-09 | Eingeleitet | TD Cowen | Buy |
2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Tempus AI Gets Bullish Boost from BTIG on Data Strength, Expansion Moves - Yahoo Finance
BTIG sets Tempus stock Buy rating with $60 target By Investing.com - Investing.com South Africa
Tempus AI initiated with a Buy at BTIG - Seeking Alpha
BTIG Initiates Tempus AI at Buy With $60 Price Target - marketscreener.com
The recent drop in prices must have disappointed Tempus AI, Inc. (NASDAQ:TEM) institutional investors who own 36% of the shares - simplywall.st
BTIG sets Tempus stock Buy rating with $60 target - Investing.com
Tempus Stock: The AI Engine Powering Healthcare (NASDAQ:TEM) - Seeking Alpha
Tempus assembles advisory board to guide oncology research - Crain's Chicago Business
Illumina, Tempus AI partner to drive genomic testing beyond cancer - MedTech Dive
Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S. - Yahoo Finance
Illumina and Tempus join forces to expand genomic testing By Investing.com - Investing.com South Africa
Illumina, Tempus AI To Collaborate To Accelerate Genomic AI Innovation - Nasdaq
Illumina, Tempus AI Collaborating to Accelerate Clinical Use of Sequencing Tests - marketscreener.com
Illumina and Tempus join forces to expand genomic testing - Investing.com Australia
Illumina And Tempus Partner To Drive The Future Of Precision Medicine Through Genomic Ai Innovation - MarketScreener
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation - PR Newswire
Tempus (TEM) stock: Analysts say AI healthcare will be the next gold rush - Investorsobserver
Smart Money Is Betting Big In TEM Options - Benzinga
3 Hot New IPOs Defying the 2025 Market Slump - The Globe and Mail
Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy? - Yahoo Finance
Is it safe to buy the Tempus AI stock dip now? - MSN
Cathie Wood's Thursday Plays: Healthcare AI And Crypto — Ark Scoops Up Tempus AI and Coinbase Stock Amid Trump Tariff CrashCoinbase Global (NASDAQ:COIN), ARK Innovation ETF (BATS:ARKK) - Benzinga
Beyond Tempus AI: 2 Health IT Stocks Poised For Growth In 2025 - Barchart.com
Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025 - Yahoo Finance
WOW!'s Senior Director of Talent Management and Senior Director - GuruFocus
Why Tempus AI Inc. (TEM) Went Down On Tuesday? - Insider Monkey
Tuesday’s 10 Worst-Performing Stocks - Insider Monkey
Cathie Wood Loads Up On $18.2 Million Worth Of Nvidia Stock, Adds $5.8 Million Worth Of Amazon Shares To Her Shopping Cart Amid Trump Tariff Upheaval - Benzinga
DnB Asset Management AS Takes $641,000 Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI, Inc. (TEM): Among Stocks That Will Profit From AI - MSN
10 Stocks That Will Profit From AI - Insider Monkey
Wayne A.I. Frederick Sells 3,000 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock - MarketBeat
Tempus AI director Jennifer Doudna sells shares worth $30,075 - Investing.com Australia
Tempus AI director Jennifer Doudna sells shares worth $30,075 By Investing.com - Investing.com Canada
Executives at Tempus AI Conduct Stock Transactions - TradingView
Tempus Fugit Ad Nevada - The National Law Review
Tempus AI director Frederick Wayne sells $136,620 in stock By Investing.com - Investing.com Canada
Tempus AI director Frederick Wayne sells $136,620 in stock - Investing.com Australia
Tempus AI Director Sells 3,000 Shares - TradingView
Does Nvidia-Backed CoreWeave's Lackluster IPO Signal the AI Stock Boom Is Officially Over? - The Motley Fool
Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock? - Yahoo
Decoding Tempus AI's Options Activity: What's the Big Picture? - Benzinga
Tempus AI Surges 43% YTD: Is It The Right Time To Invest In The Stock? - Barchart.com
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting - Business Wire
4 Healthcare Stocks With Massive Gains—and More to Come - MarketBeat
Why Tempus AI Inc. (TEM) Crashed On Wednesday? - Insider Monkey
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):